---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-040955"
form_type: "8-K"
ticker: "NUS"
cik: "0001021561"
company_name: "NU SKIN ENTERPRISES, INC."
filed_at: "2024-09-12T23:59:59+00:00"
generated_at: "2026-05-31T05:07:55.459070+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Nu Skin appoints Mark A. Zorko to board; Audit and Nominating committees

## Summary
- Mark A. Zorko appointed as director effective September 10, 2024, increasing board to nine members.
- Zorko will serve on Audit Committee and Nominating and Corporate Governance Committee.
- Cash retainer and annual equity award pro-rated to 75% due to mid-year appointment.
- Expected to enter standard indemnification agreement; no related-party transactions reported.

## SEC filing metadata
- accession: 0001140361-24-040955
- form_type: 8-K
- ticker: NUS
- cik: 0001021561
- company_name: NU SKIN ENTERPRISES, INC.
- filed_at: 2024-09-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1021561/000114036124040955/0001140361-24-040955-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1021561/000114036124040955/ef20035756_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-040955
- JSON: https://secwatch.observer/filing/0001140361-24-040955.json
- Plain text: https://secwatch.observer/filing/0001140361-24-040955.txt

## Key facts
- Executive change
  Mark A. Zorko was appointed as Director at NU SKIN ENTERPRISES, INC..
  - Action: appointed
  - Role: Director
  source text: On September 10, 2024, the Board of Directors (the “Board”) of Nu Skin Enterprises, Inc. (the “Company”) appointed Mark A. Zorko as a director of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1021561/000114036124040955/0001140361-24-040955-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.